With a truly patient-focussed approach we offer a best-in-class Early Access Program service that ensures patient, healthcare professional, and client needs are met through passionate and tailored program delivery.
Sourcing commercial drug products for clinical trials can be a complex process and is often one of the last considerations during study design. Our experienced Global Sourcing Team is uniquely positioned to support you through the commercial drug sourcing process with their deep understanding of clinical trials and commercial drug markets.
Here at Bionical Emas, within our Early Access Programs, we are harnessing the power of AI to elevate the services we provide to patients, healthcare professionals and clients. By integrating cutting-edge technology, we are able to focus our energies on providing an even greater human element.
The AI for Healthcare 2025 campaign featured in The Guardian newspaper, highlights insights from Behrad Behmardi and Daniel Holmes on how Artificial Intelligence is accelerating patient access and assisting us in bringing life-changing medicines to patients around the world.
Download here to read the full article.
